Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Anderson

Podiatrist Alamogordo, NM Doctor of Podiatric Medicine

NPI 1235101940 CMS profile 327485

2301 Indian Wells Rd, Suite A, Alamogordo, NM 88310

Open in the dashboard

General payments

$1,386,611

122 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$83,305

3 holdings reported · through program year 2025

Research they led as principal investigator

$6,760 paid to institutions, not to them · program year 2024

Through program year 2025, John Anderson of Alamogordo, NM is reported in the CMS Open Payments database as having received $1,386,611 across 122 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $6,760 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $83,305 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $52,952 12
2024 General $54,264 14
2023 General $27,097 17
2022 General $737,824 19
2021 General $504,437 27
2020 General $2,599 10
2019 General $7,437 23
2021 Ownership $43,064 1
2020 Ownership $20,021 1
2019 Ownership $20,221 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Anderson
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to John Anderson were reported at $52,952. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year John Anderson Podiatrist median Middle half National median
2019 $7,437 $196 $72–$601 $163
2020 $2,599 $118 $38–$335 $114
2021 $504,437 $169 $57–$573 $132
2022 $737,824 $220 $74–$782 $149
2023 $27,097 $208 $71–$635 $160
2024 $54,264 $237 $87–$681 $164
2025 $52,952 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Sales Inc. $729,548 2 payments
  2. Trilliant Surgical LLC. $455,835 7 payments
  3. Vilex in Tennessee, Inc. $181,454 48 payments
  4. Ortho Solutions Inc $8,346 13 payments
  5. Wright Medical Technology, Inc. $6,502 8 payments
  6. Organogenesis Inc. $2,095 6 payments
  7. Stryker Corporation $1,884 11 payments
  8. Smith+Nephew, Inc. $524 12 payments
  9. Encore Medical, LP $164 2 payments
  10. Orthofix Medical, Inc. $88 5 payments
  11. Other $172 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $729,548 2 payments
  2. Royalty or License $590,770 42 payments
  3. Consulting Fee $54,594 7 payments
  4. Travel and Lodging $5,435 19 payments
  5. Education $4,000 1 payment
  6. Food and Beverage $2,264 51 payments
Products named General payments · program years 2019–2025
  1. ALPHALOK Recon - R&D $53,527 7 payments
  2. ALPHALOK Orthopedics/Orthopedic Surgery $41,758 6 payments
  3. HINTERMANN Orthopedics $27,135 3 payments
  4. ALPHALOK Orthopedics $22,584 7 payments
  5. RD Ankle Fx $18,082 1 payment
  6. DYNEX $6,690 2 payments
  7. TCP TOTAL COMPRESSION $6,456 7 payments
  8. HINTERMANN Orthopedics/Orthopedic Surgery $5,820 1 payment
  9. RD Soft Tissue $2,225 7 payments
  10. NuCel/NuShield/Affinity $2,032 5 payments
  11. Other $9,155 78 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

330

Median for Podiatry: 160

Drug cost

$4,076

Median for Podiatry: $2,368

Branded share of claims

43.6%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 46 $734
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 36 $518
Pregabalin Generic 19 $422
Gabapentin Generic 45 $406
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 21 $391
Ciprofloxacin Hcl Generic 28 $369
Ondansetron Hcl Generic 26 $285
Acetaminophen-Codeine Acetaminophen With Codeine Brand 16 $230
Vitamin D2 Ergocalciferol (Vitamin D2) Brand 12 $174
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 13 $145

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 103 billing codes

Paid by Medicare

$125,984

Of which drugs: $24,729

Medicare patients

170

Average age 72

Services billed

2,057

105 women, 65 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 39%
Ischemic heart disease 23%
Depression 21%
Osteoporosis 21%
Chronic kidney disease 18%
COPD 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 62 470 $2,584
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 22 160 $122
Injection, ketorolac tromethamine, per 15 mg J1885 Office 47 202 $108

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in New Mexico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record